- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ 42756493
Total 875 results
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedTumor or LymphomaUnited States, France, Spain
-
Janssen Research & Development, LLCTerminatedHepatic ImpairmentGermany
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedNeoplasms | Lymphoma | Adenocarcinoma | Esophagogastric JunctionJapan
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Poland, Taiwan, China, Italy, Spain, Australia, Brazil, Argentina
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
Janssen Scientific Affairs, LLCApproved for marketingAdvanced Cancers and FGFR Genetic Alterations
-
Lung Cancer Group CologneTerminatedNSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary NeoplasmGermany
-
Janssen Research & Development, LLCCompletedNeoplasmChina, Taiwan, Korea, Republic of
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Janssen Research & Development, LLCCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerUnited States, France, Germany, United Kingdom, Belgium, Taiwan, Spain, Israel, India, Romania, Korea, Republic of, Russian Federation, Turkey, Austria, Moldova, Republic of
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid NeoplasmUnited States
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerKorea, Republic of, United States, Italy, Spain, Japan, United Kingdom, Belgium, Israel, China, Austria, France, Canada, Taiwan, Turkey, Germany, Russian Federation, Bulgaria, Poland, Greece, Brazil, Netherlands, Australia, Argentina, Mexic... and more
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Glioblastoma, IDH-Wildtype | Recurrent WHO Grade 3 GliomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
University of WashingtonJanssen Research & Development, LLCTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Double-Negative Prostate CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma and other conditionsUnited States, Puerto Rico
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam
-
Janssen Research & Development, LLCRecruitingRecurrent/Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
Mayo ClinicRecruitingProstate Adenocarcinoma | Oligometastatic Prostate CarcinomaUnited States
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingAdvanced Solid TumorsUnited States
-
Janssen Pharmaceutical K.K.RecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Janssen Research & Development, LLCRecruitingAdvanced Stage Solid TumorsSpain
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
Janssen Research & Development, LLCRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United Kingdom, United States, Poland, Germany, Brazil, Spain, Taiwan, Hungary, Japan, Canada, Argentina, Australia